1. 5-azacytidine increases the total cellular copper content and basal level metallothionein mRNA accumulation of human Hep G2 cells
- Author
-
R Foster, Lashitew Gedamu, and Nadia Jahroudi
- Subjects
Biophysics ,chemistry.chemical_element ,Cycloheximide ,Biology ,Biochemistry ,Gene Expression Regulation, Enzymologic ,chemistry.chemical_compound ,Liver Neoplasms, Experimental ,Structural Biology ,Gene expression ,Tumor Cells, Cultured ,Genetics ,Animals ,Humans ,Metallothionein ,RNA, Messenger ,Spectrophotometry, Atomic ,Blotting, Northern ,Copper ,Molecular biology ,In vitro ,Hep G2 ,chemistry ,Cell culture ,Enzyme Induction ,Azacitidine ,Intracellular - Abstract
In this study we have demonstrated the ability of 5-azacytidine to elevate the basal level expression of the metallothionein (MT)-IF and MT-IG genes and increase the basal level expression of the MT-IIA gene in Hep G2 cells, a cell line which exhibits heavy metal inducible MT gene expression. Atomic absorption analysis of 5-azacytidine treated Hep G2 cells detected a 2-fold increase in the total cellular copper content. Pretreatment of 5-azacytidine exposed cells within hydroxyurea and cycloheximide indicated that the increase in total cellular copper content was a direct response to 5-azacytidine treatment. S1 nuclease analysis illustrated that pretreatment of Hep G2 cells with KCN, a copper specific chelator and uptake inhibitor, suppressed 5-azacytidine- and copper-inducible MT-IG gene expression. Thus, the increase in MT gene expression in response to 5-azacytidine treatment can be correlated to an increase in the total cellular copper content. Possible mechanisms on how 5-azacytidine could alter the influx/efflux of copper in Hep G2 cells are discussed.
- Published
- 1991
- Full Text
- View/download PDF